Overview

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.
Phase:
Phase 4
Details
Lead Sponsor:
Deborah Gentile
West Penn Allegheny Health System
Collaborator:
AstraZeneca
Treatments:
Albuterol
Budesonide